117 related articles for article (PubMed ID: 18691140)
1. ADAM8 in allergy.
Matsuno O; Kumamoto T; Higuchi Y
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):108-12. PubMed ID: 18691140
[TBL] [Abstract][Full Text] [Related]
2. Elevated soluble ADAM8 in bronchoalveolar lavage fluid in patients with eosinophilic pneumonia.
Matsuno O; Miyazaki E; Nureki S; Ueno T; Ando M; Ito K; Kumamoto T; Higuchi Y
Int Arch Allergy Immunol; 2007; 142(4):285-90. PubMed ID: 17124430
[TBL] [Abstract][Full Text] [Related]
3. A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.
Chen J; Deng L; Dreymüller D; Jiang X; Long J; Duan Y; Wang Y; Luo M; Lin F; Mao L; Müller B; Koller G; Bartsch JW
Sci Rep; 2016 Jul; 6():30451. PubMed ID: 27458083
[TBL] [Abstract][Full Text] [Related]
4. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23.
Fourie AM; Coles F; Moreno V; Karlsson L
J Biol Chem; 2003 Aug; 278(33):30469-77. PubMed ID: 12777399
[TBL] [Abstract][Full Text] [Related]
5. The detection of ADAM8 protein on cells of the human immune system and the demonstration of its expression on peripheral blood B cells, dendritic cells and monocyte subsets.
Richens J; Fairclough L; Ghaemmaghami AM; Mahdavi J; Shakib F; Sewell HF
Immunobiology; 2007; 212(1):29-38. PubMed ID: 17270707
[TBL] [Abstract][Full Text] [Related]
6. Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry.
Matsuno O; Ono E; Ueno T; Takenaka R; Nishitake T; Hiroshige S; Miyazaki E; Kumamoto T; Higuchi Y
Respir Med; 2010 Jan; 104(1):34-9. PubMed ID: 19625177
[TBL] [Abstract][Full Text] [Related]
7. Role of ADAM8 in experimental asthma.
Matsuno O; Miyazaki E; Nureki S; Ueno T; Kumamoto T; Higuchi Y
Immunol Lett; 2006 Jan; 102(1):67-73. PubMed ID: 16154205
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S; Reipschläger S; Wildeboer D; Lichtenthaler SF; Mitterreiter S; Guan Z; Moss ML; Bartsch JW
Biol Chem; 2006 Mar; 387(3):337-46. PubMed ID: 16542157
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of a disintegrin and metalloprotease 8 in allergic rhinitis.
Park IH; Choi SW; Choi H; Kim TH; Lee SH; Lee SH; Lee HM
Am J Rhinol Allergy; 2011; 25(3):107-11. PubMed ID: 21679521
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.
King NE; Zimmermann N; Pope SM; Fulkerson PC; Nikolaidis NM; Mishra A; Witte DP; Rothenberg ME
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):257-65. PubMed ID: 15087305
[TBL] [Abstract][Full Text] [Related]
11. The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma.
Naus S; Blanchet MR; Gossens K; Zaph C; Bartsch JW; McNagny KM; Ziltener HJ
Am J Respir Crit Care Med; 2010 Jun; 181(12):1318-28. PubMed ID: 20194813
[TBL] [Abstract][Full Text] [Related]
12. Sputum ADAM8 expression is increased in severe asthma and COPD.
Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
[TBL] [Abstract][Full Text] [Related]
13. IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration.
Johansson MW; Khanna M; Bortnov V; Annis DS; Nguyen CL; Mosher DF
Clin Exp Allergy; 2017 Oct; 47(10):1263-1274. PubMed ID: 28378503
[TBL] [Abstract][Full Text] [Related]
14. Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays.
Schlomann U; Dorzweiler K; Nuti E; Tuccinardi T; Rossello A; Bartsch JW
Biol Chem; 2019 May; 400(6):801-810. PubMed ID: 30738011
[TBL] [Abstract][Full Text] [Related]
15. ADAM8: a new therapeutic target for asthma.
Knolle MD; Owen CA
Expert Opin Ther Targets; 2009 May; 13(5):523-40. PubMed ID: 19397475
[TBL] [Abstract][Full Text] [Related]
16. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
17. Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity.
Hall T; Leone JW; Wiese JF; Griggs DW; Pegg LE; Pauley AM; Tomasselli AG; Zack MD
Biosci Rep; 2009 Aug; 29(4):217-28. PubMed ID: 18811590
[TBL] [Abstract][Full Text] [Related]
18. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
[TBL] [Abstract][Full Text] [Related]
19. The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation.
Dreymueller D; Pruessmeyer J; Schumacher J; Fellendorf S; Hess FM; Seifert A; Babendreyer A; Bartsch JW; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L602-L614. PubMed ID: 28596294
[TBL] [Abstract][Full Text] [Related]
20. ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.
Hall T; Pegg LE; Pauley AM; Fischer HD; Tomasselli AG; Zack MD
Arch Biochem Biophys; 2009 Nov; 491(1-2):106-11. PubMed ID: 19766586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
